إعلان
إعلان

APYX

APYX logo

Apyx Medical Corporation Common Stock

3.52
USD
برعاية
+0.08
+2.33%
٣١ ديسمبر, ١٥:٥٥ UTC -5
مغلق
exchange

بعد الإغلاق

3.63

+0.11
+3.12%

تقارير أرباح APYX

النسبة الإيجابية المفاجئة

APYX تفوق 27 من 40 آخر التقديرات.

68%

التقرير التالي

بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$17.78M
/
-$0.06
التغير الضمني من Q3 25 (Revenue/ EPS)
+38.06%
/
+20.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+25.01%
/
-50.00%

Apyx Medical Corporation Common Stock earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, APYX reported earnings of -0.05 USD per share (EPS) for Q3 25, beating the estimate of -0.10 USD, resulting in a 52.20% surprise. Revenue reached 12.88 مليون, compared to an expected 12.24 مليون, with a 5.18% difference. The market reacted with a +6.69% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 17.78 مليون USD, implying an increase of 20.00% EPS, and increase of 38.06% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Apyx Medical Corporation Common Stock reported EPS of -$0.05, beating estimates by 52.2%, and revenue of $12.88M, 5.18% above expectations.
The stock price moved up 6.69%, changed from $3.14 before the earnings release to $3.35 the day after.
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
Based on 7 analysts, Apyx Medical Corporation Common Stock is expected to report EPS of -$0.06 and revenue of $17.78M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان